World's Best Scientists 2026 revealed!
Michelle Rosenzwajg

Michelle Rosenzwajg

D-Index & Metrics

Immunology

D-Index
50
Citations
10355
World Ranking
4228
National Ranking
201

Overview

Michelle Rosenzwajg is affiliated with Sorbonne University in France. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with significant contributions in Immunology, Rheumatology, Oncology, Genetics, and Pulmonary and Respiratory Medicine.

The scientist's work covers multiple main topics, including:

  • Systemic Lupus Erythematosus Research
  • Immune Cell Function and Interaction
  • Cancer Immunotherapy and Biomarkers
  • Adolescent and Pediatric Healthcare
  • T-cell and B-cell Immunology
  • Vasculitis and related conditions
  • Tryptophan and brain disorders

Michelle Rosenzwajg has frequently published in venues such as:

  • Annals of the Rheumatic Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Autoimmunity
  • La Revue de Médecine Interne
  • Nature Medicine

Recent papers featuring their research include:

  • Fecal microbiota transplantation to maintain remission in Crohn's disease: a pilot randomized controlled study, 2020, Microbiome
  • Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis, 2023, Cancer Discovery
  • Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities, 2020, Autoimmunity Reviews
  • Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial, 2022, Critical Care
  • Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding study, 2020, Diabetologia

The scientist collaborates frequently with several researchers, including:

  • David Klatzmann
  • Nicolas Tchitchek
  • P. Cacoub
  • Roberta Lorenzon
  • David Saadoun

Best Publications

  • Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis.

    David Saadoun;Michelle Rosenzwajg;Florence Joly;Adrien Six

  • Differentiation of human dendritic cells from monocytes in vitro

    Françoise Chapuis;Michelle Rosenzwajg;Micael Yagello;Marianne Ekman

  • Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial

    Agnès Hartemann;Gilbert Bensimon;Christine A Payan;Sophie Jacqueminet

  • Therapeutic Effects of Human Mesenchymal Stem Cell–derived Microvesicles in Severe Pneumonia in Mice

    Antoine Monsel;Ying-gang Zhu;Stephane Gennai;Qi Hao

  • Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial

    Michelle Rosenzwajg;Roberta Lorenzon;Patrice Cacoub;Hang Phuong Pham

  • Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue

    nathalie chaput;Samy Louafi;armelle Bardier;frederic charlotte

  • Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study

    Harry Sokol;Cecilia Landman;Philippe Seksik;Laurence Berard

  • Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients.

    Michelle Rosenzwajg;Guillaume Churlaud;Roberto Mallone;Adrien Six

  • Th1 and Th17 Cytokines Drive Inflammation in Takayasu Arteritis

    D. Saadoun;M. Garrido;C. Comarmond;A. C. Desbois

  • Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes.

    Aixin Yu;Isaac Snowhite;Francesco Vendrame;Michelle Rosenzwajg;Michelle Rosenzwajg

  • Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease

    Guillaume Geri;Benjamin Terrier;Michelle Rosenzwajg;Bertrand Wechsler

  • Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation

    Benjamin Terrier;Benjamin Terrier;Benjamin Terrier;Nicolas Derian;Nicolas Derian;Yoland Schoindre;Wahiba Chaara;Wahiba Chaara

  • Human and Mouse CD8+CD25+FOXP3+ Regulatory T Cells at Steady State and during Interleukin-2 Therapy

    Guillaume Churlaud;Fabien Pitoiset;Fabien Pitoiset;Fadi Jebbawi;Roberta Lorenzon;Roberta Lorenzon

  • Constrained intracellular survival of Mycobacterium tuberculosis in human dendritic cells

    Ludovic Tailleux;Olivier Neyrolles;Stéphanie Honoré-Bouakline;Emmanuelle Perret

  • Human Dendritic Cell Differentiation Pathway From CD34+ Hematopoietic Precursor Cells

    Michelle Rosenzwajg;Bruno Canque;Jean Claude Gluckman

  • MTCP-1: a novel gene on the human chromosome Xq28 translocated to the T cell receptor alpha/delta locus in mature T cell proliferations.

    M.-H. Stern;J. Soulier;M. Rosenzwajg;K. Nakahara

  • Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis.

    Benjamin Terrier;Guillaume Geri;Wahiba Chaara;Yves Allenbach

  • Interleukin-25: a cytokine linking eosinophils and adaptive immunity in Churg-Strauss syndrome.

    Benjamin Terrier;Ivan Bièche;Thierry Maisonobe;Ingrid Laurendeau

  • Interleukin 21 Correlates with T Cell and B Cell Subset Alterations in Systemic Lupus Erythematosus

    Benjamin Terrier;Nathalie Costedoat-Chalumeau;Marlène Garrido;Guillaume Geri

  • B- and T-cell subpopulations in patients with severe idiopathic membranous nephropathy may predict an early response to rituximab

    Michelle Rosenzwajg;Michelle Rosenzwajg;Eva Languille;Eva Languille;Hanna Debiec;Hanna Debiec;Joana Hygino

  • CD4+CD25+ Regulatory T Cell Depletion Improves the Graft-Versus-Tumor Effect of Donor Lymphocytes After Allogeneic Hematopoietic Stem Cell Transplantation

    Sébastien Maury;François M. Lemoine;Yosr Hicheri;Michelle Rosenzwajg

Frequent Co-Authors

David Klatzmann
David Klatzmann Sorbonne University
David Saadoun
David Saadoun Université Paris Cité
Patrice Cacoub
Patrice Cacoub Sorbonne University
Lucile Musset
Lucile Musset Sorbonne University
Claude C.A. Bernard
Claude C.A. Bernard Monash University
Olivier Benveniste
Olivier Benveniste Sorbonne University
Nathalie Chaput
Nathalie Chaput Institut Gustave Roussy
Eric Vicaut
Eric Vicaut Université Paris Cité
Alberto Pugliese
Alberto Pugliese University of Miami

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring online degree options in nursing and healthcare can broaden career opportunities. Many students start with an best online BSN programs for non nurses to transition into the healthcare field without prior experience. These programs are designed to provide foundational nursing knowledge quickly and efficiently.

Once foundational knowledge is gained, students often seek advanced credentials. Accelerated pathways such as accelerated NP programs online offer a faster route to becoming Nurse Practitioners, combining flexibility with rigorous training that complements immunology expertise.

For those looking for more accessible entry points, accelerated nursing programs near me provide options with streamlined admissions and intensive curricula, ideal for dedicated students eager to advance quickly.

Similarly, easy admission LPN programs can serve as practical stepping stones into healthcare careers, offering foundational skills needed for patient care and immunology-related roles in clinical settings.

Best Scientists Citing Michelle Rosenzwajg

Trending Scientists